COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium
JCO Oncology Advances · 2026-01 · 3 (1)
DOI: 10.1200/oa-25-00191 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Advances, 2026-01. Verfasst von Alaina J Brown und 39 weiteren Autor:innen. Beteiligte Einrichtung: Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, TN. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Limited information exists regarding outcome severity among gynecologic cancer patients with SARS-CoV-2 infection. The objective of this study was to describe patient, cancer, and COVID-19 characteristics, and to identify factors associated with COVID-19 severity. METHODS Gynecologic cancer patients with SARS-CoV-2 infection were identified from the international COVID-19 and Cancer Consortium registry. We estimated odds ratios (ORs) for associations with severity of COVID-19 outcomes. Multivariable models included adjustment for age, race, cancer status, and time period of COVID-19 diagnosis. RESULTS Of 920 patients, 438 patients (48%) had endometrial, 249 (27%) had ovarian, 198 (22%) had cervical, and 44 (5%) had vulvar/vaginal cancers. Most were from the United States (86%) and non-Hispanic White (48%). Median age was 62 years (IQR, 52-71). When diagnosed with COVID-19, 457 (49%) patients were in remission and 343 (37%) had active disease. Outcomes included hospitalization in 452 patients (49%), intensive care unit admittance in 107 patients (12%), mechanical ventilation in 70 patients (8%), and death within 30 days of testing positive for SARS-CoV-2 in 91 patients (10%). In multivariable models, increasing age (adjusted OR, 1.35 [95% CI, 1.23 to 1.49]) and non-Hispanic Black race (adjusted OR, 1.75 [95% CI, 1.24 to 2.48]) were associated with increased COVID-19 severity, as were cardiac (adjusted OR, 1.85 [95% CI, 1.36 to 2.52]), pulmonary (adjusted OR, 1.58 [95% CI, 1.12 to 2.22]), and renal (adjusted OR, 2.18 [95% CI, 1.48 to 3.19]) comorbidities. Patients in remission
Autor:innen und Institutionen
- Vanderbilt-Ingram Cancer Center at Vanderbilt University Medical Center, Nashville, TN.
- Rhode Island Hospital, Providence, RI.
- Brown University, Providence, RI.
- Instituto Nacional de Cancerologia, Mexico City, Mexico.
- Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, MI.
- University of Arkansas for Medical Sciences, Little Rock, Fayetteville, AR.
ORCID-Profile: Alaina J Brown, Chih-Yuan Hsu, Aleenah Mohsin, Lauren S Prescott, Erika Ruiz-Garcia, Diana Vilar-Compte, José Antonio García-Gordillo, Clara Hwang, Sunny R K Singh, Trisha M Wise-Draper, Rana R McKay, Padmanabh Bhatt, Jonathan A Cosin, Babar Bashir, Karen Russell, Susan Halabi, Hannah McManus, Melissa K Accordino, Monika Joshi, Hyma V Polimera, Salvatore A Del Prete, Suzanne J Rose, Bryan A Faller, Marc Eid, Sanjay Mishra, Roisin E O'Cearbhaill, Marta A Crispens, Yu Shyr, Jeremy L Warner
Förderung
- NCI NIH HHS
Zitieren
APA
Brown, A. J., Hsu, C. Y., Mohsin, A., Prescott, L. S., Beeghly, A., Ruiz-Garcia, E., Vilar-Compte, D., García-Gordillo, J. A., Hwang, C., Hijaz, M., Buekers, T., Singh, S. R. K., Wise-Draper, T. M., Ferrara, E. K., McKay, R. R., Ajmera, A., Mariano, M., Bhatt, P., Nagaraj, G., …, & Warner, J. L. (2026). COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium. JCO Oncology Advances, 3(1). https://doi.org/10.1200/oa-25-00191
Vancouver
Brown AJ, Hsu CY, Mohsin A, Prescott LS, Beeghly A, Ruiz-Garcia E, et al. COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium. JCO Oncology Advances. 2026;3(1). doi:10.1200/oa-25-00191
BibTeX
@article{Brown2026,
author = {Brown, Alaina J and Hsu, Chih-Yuan and Mohsin, Aleenah and Prescott, Lauren S and Beeghly, Alicia and Ruiz-Garcia, Erika and Vilar-Compte, Diana and García-Gordillo, José Antonio and Hwang, Clara and Hijaz, Miriana and Buekers, Thomas and Singh, Sunny R K and Wise-Draper, Trisha M and Ferrara, Elizabeth K and McKay, Rana R and Ajmera, Archana and Mariano, Melissa and Bhatt, Padmanabh and Nagaraj, Gayathri and Puc, Matthew and Cosin, Jonathan A and Bashir, Babar and Russell, Karen and Halabi, Susan and McManus, Hannah and Accordino, Melissa K and Mavromatis, Blanche H and Joshi, Monika and Polimera, Hyma V and Del Prete, Salvatore A and Rose, Suzanne J and Subbiah, Suki and Faller, Bryan A and Mansoor, Abdul Hai and Eid, Marc and Mishra, Sanjay and O'Cearbhaill, Roisin E and Crispens, Marta A and Shyr, Yu and Warner, Jeremy L},
title = {COVID-19 in Patients With Gynecologic Cancer: A Report From the COVID-19 and Cancer Consortium},
journal = {JCO Oncology Advances},
year = {2026},
volume = {3},
number = {1},
doi = {10.1200/oa-25-00191}
}
EUVIMED